Incorporating Immuno-oncology Agents into Solid and Liquid Tumor Treatment Paradigms

The goal of this initiative is to help medical oncology and hematology-oncology physicians and advanced practitioners in community and academic settings to integrate checkpoint inhibitors into cancer treatment regimens and understand their unique safety and response profiles.

ASCO Highlights 2017

Faculty:  Jeffrey Clarke, MD


Credits:
 0.5 AMA PRA Category 1 Credit(s)™

Expert Recap immuno-oncology course

Faculty:  Jeffrey Clarke, MD


Credits:
 0.5 AMA PRA Category 1 Credit(s)™

ESMO Highlights 2017

Faculty:  Jeffrey Clarke, MD


Credits:
 0.5 AMA PRA Category 1 Credit(s)™

Expert Recap immuno-oncology course

Faculty:  Jeffrey Clarke, MD


Credits:
 0.5 AMA PRA Category 1 Credit(s)™